Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-04-13

Clinical Trial Update: Transcription Factor Runx2 in Necrotic Femoral Head Tissue

View source ↗

Summary

This completed trial investigates the transcription factor Runx2 in necrotic femoral head tissue.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Shengjing Hospital | Conditions: Osteonecrosis of Femoral Head | Status: COMPLETED